Laura M. Bohn, Ph.D.
Affiliations: | 2003-2008 | The Ohio State University College of Medicine | |
| 2009- | Molecular Therapeutics & Neuroscience | Scripps Research Institute Florida |
Area:
Pharmacology, Neuropharmacology, NeuroscienceWebsite:
http://www.scripps.edu/research/faculty/bohnGoogle:
"Laura Bohn"Cross-listing: Neurotree
Parents
Sign in to add mentor| Carmine Coscia | grad student | Saint Louis University School of Medicine | |
| Carmine J. Coscia | grad student | 1993-1999 | Saint Louis University School of Medicine (Neurotree) |
| Marc Caron | post-doc | 1999-2003 | Duke |
Children
Sign in to add trainee| Snezana T Dimova | research assistant | 2022-2024 | Scripps Institute, Florida (Neurotree) |
| Kirsten M. Raehal | grad student | The Ohio State University College of Medicine | |
| Cullen L. Schmid | grad student | 2011 | Ohio State |
| Kirsten M. Raehal | post-doc | The Scripps Reserach Institute, Scripps Florida | |
| Kimberly M. Lovell | post-doc | 2012- | Scripps Research Institute Florida |
Collaborators
Sign in to add collaborator| Michael A. Tarselli | collaborator | 2009-2011 | Scripps Research Institute Florida |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Trojniak AE, Dang VQ, Czekner KM, et al. (2024) Synthesis and evaluation of 3,4,5-trisubstituted triazoles as G protein-biased kappa opioid receptor agonists. European Journal of Medicinal Chemistry. 276: 116627 |
| Brust CA, Swanson MA, Bohn LM. (2023) Structural and functional insights into the G protein-coupled receptors: CB1 and CB2. Biochemical Society Transactions. 51: 1533-1543 |
| Hill SJ, Dao N, Dang VQ, et al. (2023) A Route to Potent, Selective, and Biased Salvinorin Chemical Space. Acs Central Science. 9: 1567-1574 |
| Acevedo-Canabal A, Grim TW, Schmid CL, et al. (2023) Hyperactivity in Mice Induced by Opioid Agonists with Partial Intrinsic Efficacy and Biased Agonism Administered Alone and in Combination with Morphine. Biomolecules. 13 |
| Shevick SL, Freeman SM, Tong G, et al. (2022) Asymmetric Syntheses of (+)- and (-)-Collybolide Enable Reevaluation of -Opioid Receptor Agonism. Acs Central Science. 8: 948-954 |
| Brust CA, Ho JH, Stahl E, et al. (2022) Functional analysis of key residues involved in CB1 and CB2 activation. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology |
| Stahl E, Schmid CL, Acevedo-Canabal A, et al. (2022) Irreversible and noncompetitive mu opioid receptor agonists. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology |
| Ma H, Brust T, Frankowski KJ, et al. (2022) Advances in Sulfonamide Kappa Opioid Receptor Antagonists: Structural Refinement and Evaluation of CNS Clearance. Acs Chemical Neuroscience. 13: 1315-1332 |
| Kolb P, Kenakin T, Alexander SPH, et al. (2022) Community Guidelines for GPCR Ligand Bias: IUPHAR Review XX. British Journal of Pharmacology |
| Stahl EL, Schmid CL, Acevedo-Canabal A, et al. (2021) G protein signaling-biased mu opioid receptor agonists that produce sustained G protein activation are noncompetitive agonists. Proceedings of the National Academy of Sciences of the United States of America. 118 |